Article History
Received: 18 March 2024
Accepted: 30 April 2024
First Online: 25 May 2024
Declarations
:
: This study was performed by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. V116 is being developed by Merck & Co., Inc., Rahway, NJ, USA. Zinan Yi, Kwame Owusu-Edusei and Kelly D. Johnson are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own stock and/or stock options in Merck & Co., Inc., Rahway, NJ, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
: This article does not contain any new studies with human participants or animals performed by any of the authors.